Table S5 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection

Table S5 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection

<p>Table S5: Associations between driver mutations in BC and common risk factors</p>

Sábháilte in:

Sonraí bibleagrafaíochta
Príomhchruthaitheoir:	Nina Rao (15321199) (author)
Rannpháirtithe:	Gabriel J. Starrett (16624138) (author), Mary L. Piaskowski (17079483) (author), Kelly E. Butler (17079486) (author), Yelena Golubeva (17079489) (author), Wusheng Yan (17079492) (author), Scott M. Lawrence (17079495) (author), Michael Dean (14946283) (author), Montserrat Garcia-Closas (15035106) (author), Dalsu Baris (15321208) (author), Alison Johnson (15035103) (author), Molly Schwenn (15321211) (author), Nuria Malats (14943841) (author), Francisco X. Real (15337922) (author), Manolis Kogevinas (13368975) (author), Nathaniel Rothman (15321220) (author), Debra T. Silverman (15321223) (author), Lars Dyrskjøt (15054430) (author), Christopher B. Buck (17079498) (author), Stella Koutros (15035094) (author), Ludmila Prokunina-Olsson (15021962) (author)
Foilsithe / Cruthaithe:	2025
Ábhair:	Cancer Cancer Biology Cancer Detection and Diagnosis Epidemiology Biomarkers Genetic biomarkers Genitourinary Cancers Bladder cancer Methodology and Modeling Viral Oncogenesis DNA tumor viruses
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla

Table S1 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
de réir: Nina Rao (15321199)
Foilsithe / Cruthaithe: (2025)

Table S2 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
de réir: Nina Rao (15321199)
Foilsithe / Cruthaithe: (2025)

Table S3 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
de réir: Nina Rao (15321199)
Foilsithe / Cruthaithe: (2025)

Table S4 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
de réir: Nina Rao (15321199)
Foilsithe / Cruthaithe: (2025)

Table S6 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
de réir: Nina Rao (15321199)
Foilsithe / Cruthaithe: (2025)

Table S7 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
de réir: Nina Rao (15321199)
Foilsithe / Cruthaithe: (2025)

Figure 1 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
de réir: Alba L. Combita (22677298)
Foilsithe / Cruthaithe: (2025)

Figure 2 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
de réir: Alba L. Combita (22677298)
Foilsithe / Cruthaithe: (2025)

Figure 3 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
de réir: Alba L. Combita (22677298)
Foilsithe / Cruthaithe: (2025)

Figure 4 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
de réir: Alba L. Combita (22677298)
Foilsithe / Cruthaithe: (2025)

Figure 5 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
de réir: Alba L. Combita (22677298)
Foilsithe / Cruthaithe: (2025)

Table 1 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
de réir: Alba L. Combita (22677298)
Foilsithe / Cruthaithe: (2025)

Table 1 from Addressing Common Misuses and Pitfalls of <i>P</i> values in Biomedical Research
de réir: Ming Wang (8809334)
Foilsithe / Cruthaithe: (2025)

Supplementary Data from Genetic Modulation of <i>BET1L</i> Confers Colorectal Cancer Susceptibility by Reducing miRNA Binding and m<sup>6</sup>A Modification
de réir: Shuwei Li (16437116)
Foilsithe / Cruthaithe: (2025)

Supplementary Tables from The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer
de réir: Weisi Liu (14963321)
Foilsithe / Cruthaithe: (2025)

Supplementary Video from The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer
de réir: Weisi Liu (14963321)
Foilsithe / Cruthaithe: (2025)

Supplementary Data from Profiling the Somatic Mutational Landscape of Breast Tumors from Hispanic/Latina Women Reveals Conserved and Unique Characteristics
de réir: Yuan Chun Ding (16721349)
Foilsithe / Cruthaithe: (2025)

Supplementary Data from Genome-Wide Analysis of Rare Haplotypes Associated with Breast Cancer Risk
de réir: Fan Wang (14963418)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S1 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
de réir: Athanasios Bikas (16006076)
Foilsithe / Cruthaithe: (2025)

Figure 1 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
de réir: Erwei Zeng (14958443)
Foilsithe / Cruthaithe: (2025)

Figure 2 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
de réir: Erwei Zeng (14958443)
Foilsithe / Cruthaithe: (2025)

Figure 3 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
de réir: Erwei Zeng (14958443)
Foilsithe / Cruthaithe: (2025)

Figure 4 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
de réir: Erwei Zeng (14958443)
Foilsithe / Cruthaithe: (2025)

Table 1 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
de réir: Erwei Zeng (14958443)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S1 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
de réir: Emil Christensen (15054394)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S2 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
de réir: Emil Christensen (15054394)
Foilsithe / Cruthaithe: (2025)

Supplementary Tables S1-S5 from Novel Genomic Risk Stratification Model for Primary Gastrointestinal Stromal Tumors (GIST) in the Adjuvant Therapy Era
de réir: Josephine K. Dermawan (17079555)
Foilsithe / Cruthaithe: (2025)

Characterization of a Novel Porcine Circovirus Type 2a Sequence and Anti-Viral Evaluation of Matrine and Sanguinarine Combined with Network Pharmacology and Molecular Docking
de réir: WENTING Qiao (22587494)
Foilsithe / Cruthaithe: (2025)

Supplementary Data 2 from Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study
de réir: Ismael Fernández-Miranda (15051932)
Foilsithe / Cruthaithe: (2025)

Supplementary Tables S1-S12 from Gene-Level Germline Contributions to Clinical Risk of Recurrence Scores in Black and White Patients with Breast Cancer
de réir: Achal Patel (5853731)
Foilsithe / Cruthaithe: (2025)

Figure S1 from Estimation of Neutral Mutation Rates and Quantification of Somatic Variant Selection Using cancereffectsizeR
de réir: Jeffrey D. Mandell (14963909)
Foilsithe / Cruthaithe: (2025)

Table S1-S8 from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
de réir: Ruiyun Zhang (17142498)
Foilsithe / Cruthaithe: (2025)

Supplementary Figure S1 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
de réir: Sarita Paudel (15047430)
Foilsithe / Cruthaithe: (2025)

Supplementary Figure S2 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
de réir: Sarita Paudel (15047430)
Foilsithe / Cruthaithe: (2025)

Supplementary Figure S3 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
de réir: Sarita Paudel (15047430)
Foilsithe / Cruthaithe: (2025)

Supplementary Figure S4 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
de réir: Sarita Paudel (15047430)
Foilsithe / Cruthaithe: (2025)

Supplementary Figure S5 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
de réir: Sarita Paudel (15047430)
Foilsithe / Cruthaithe: (2025)

Supplementary Figure S6 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
de réir: Sarita Paudel (15047430)
Foilsithe / Cruthaithe: (2025)

Supplementary Figure S1 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
de réir: Leon J. Wils (15055780)
Foilsithe / Cruthaithe: (2025)

Supplementary Figure S10 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
de réir: Leon J. Wils (15055780)
Foilsithe / Cruthaithe: (2025)

Cannot write session to /tmp/vufind_sessions/sess_vqdfmognddhlm2ctdc10lbnjv2